# Effects of Voriconazole on the Pharmacokinetics and Pharmacodynamics of Oral Buprenorphine: A Two-phase Cross-over Study in Healthy Subjects

> **NCT01466803** · PHASE1 · COMPLETED · sponsor: **Turku University Hospital** · enrollment: 12 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Placebo
- **DRUG:** Vorikonazole

## Key facts

- **NCT ID:** NCT01466803
- **Lead sponsor:** Turku University Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2013-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01466803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01466803, "Effects of Voriconazole on the Pharmacokinetics and Pharmacodynamics of Oral Buprenorphine: A Two-phase Cross-over Study in Healthy Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01466803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*